FAQ on TDS

  • What is testosterone?

    Testosterone is a hormone produced naturally by the testicles, and is important for a man’s physical and emotional well-being. It’s responsible for many things in the body, including the normal growth of muscle and bone, the production of sperm, and the desire to have sex.

    Find out more about testosterone and TDS.

  • How common is TDS?

    It’s quite common actually, 8% of men in Australia aged between 50 and 79 may be affected by TDS.3

  • What are the signs and symptoms of TDS?

    Common symptoms of TDS include tiredness, reduced well-being, low mood or depression, loss of concentration, hot flashes and sweats, weight gain, male breasts, loss of muscle mass and strength, as well as loss of body hair. Sexual symptoms include reduced sex drive, problems with getting or keeping an erection, and difficulty in achieving orgasm. Some men with TDS have all of these symptoms, while others may only have a few. None of these symptoms are specific to TDS, so it is important to talk to a doctor to make sure that TDS is not confused with other medical conditions.

  • What conditions might indicate an increased risk?

    The chances of finding TDS are higher when men have certain other conditions such as obesity, diabetes, high blood pressure, heart disease, asthma, chronic obstructive pulmonary disease (COPD) and osteoporosis.

FAQ on TRT

  • What is TRT?

    TRT stands for Testosterone Replacement Therapy. This is used to treat Testosterone Deficiency Syndrome (TDS). The aim of TRT is to return testosterone levels back to normal to improve quality of life. Different types of TRT include gels applied to the skin and injections.

References:

  • 1

    Morley JE, Charlton E, Patrick P, Kaiser FE, Cadeau P, McCready D, et al. Metabolism. 2000;49:1239-1242.

  • 2

    Available from: http://andrologyaustralia.org/booklets/androgen-deficiency/

  • 3

    BSSM, Guidelines on the management of sexual problems in men: the role of androgen, 2010.

  • 4

    Bhasin S, et al. J Clin Endocrin Metab 2010;95:2536-2559.

  • 5

    Low Testosterone. Available at andrologyaustralia.org/your-health/testosterone/ (Accessed December 2018)

  • 6

    Harman SM, et al. J Clin Endocrinol Metab 2001;86:724-731.

  • 7

    Torkler S, et al. Atherosclerosis 2011;14:176-182.

  • 8

    Mäkinen Jl, et al. Atherosclerosis 2008;197:688-693.

  • 9

    Dohle G et al. EAU 2014:1-28.

  • 10

    Zitzmann M, et al. J Clin Endocrinol Metab 2006;91:4335-4343.

  • 11

    Yeap B, et al. MJA 2016: 205 (5): 1-5

  • 12

    Testogel Australian Approved Product Information, 24 October 2014. Available from www.besins-healthcare.com.au/PI

  • 13

    Wang C, et al. J Clin Endocrinol Metab 2000;85:964-969.

  • 14

    Swerdloff RS, et al. J Clin Endocrinol Metab 2000;85:4500-4510.

  • 15

    Wang C, et al. J Clin Endocrinol Metab 2004;89:2085-2098.

  • 16

    Behre HM, et al. Aging Male 2012;15:198-207.

  • 17

    Heufelder AE, et al. J Andrology 2009;30:726-733.

  • 18

    Lunenfeld B Oettel M. Aging Health 2009;5:227-245.

  • 19

    Bremmer WJ. et al. J Clin Endocrinol Metab 1983;56:1271-1281.

  • 20

    Lunenfeld B, et al. Aging Male 2013;16:143-150.

  • 21

    Reandron Australian Approved Product Information, 25 September 2015.

  • 22

    Primoteston Depot Australian Approved Product Information, 25 September 2015.

  • 23

    Androderm Australian Approved Product Information, 13 March 2013.

  • 24

    Pharmaceutical Benefits Scheme. Available at http://www.pbs.gov.au.
    Accessed Oct 2017.

  • 25

    Yeap B, et al. Med J Aust 2016; 205 (4): 173-178

  • 26

    Reandron Australian Approved Product Information, 25 September 2015.

  • 27

    Primoteston Depot Australian Approved Product Information, 25 September 2015.

  • 28

    Androderm Australian Approved Product Information, 13 March 2013.